LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma
Related Experiment Video
Updated: Dec 3, 2025
Fu-Bo Chen1, Peng Wu2, Rong Zhou1
1Department of Stomatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Abstract:
Recent studies have revealed that long non-coding RNAs (lncRNAs) involve in the progression of oral squamous cell carcinoma (OSCC). These lncRNAs have emerged as biomarkers or therapeutic targets for OSCC. We here aimed to investigate the role of lncRNA LINC01315 in OSCC and the related mechanisms. LINC01315 and DLG3 were determined to be poorly expressed while microRNA-211 (miR-211) was highly expressed in OSCC tissues and cells using RT-qPCR and western blot analysis. Based on the results obtained from dual-luciferase reporter gene, RIP, and FISH assays, LINC01315 was found to upregulate DLG3 expression by competitively binding to miR-211. Upon altering the expression of LINC01315, and/or miR-211 in OSCC cells with shRNA, mimic, or an inhibitor, we assessed their effects on OSCC cell proliferation, migration, invasion, and apoptosis. LINC01315 knockdown enhanced OSCC cell proliferation, migration and invasion, but dampened their apoptosis, all of which could be reversed by miR-211 inhibition. Elevation of DLG3, a target gene of miR-211, activated the Hippo signaling pathway, whereby suppressing OSCC progression in vitro. Finally, their roles in tumor growth were validated in vivo. These findings suggest that LINC01315 elevates DLG3 expression by competitively binding to miR-211, thereby suppressing OSCC progression.
Insights
Long non-coding RNA LINC01315 acts as a tumor suppressor in oral squamous cell carcinoma (OSCC) by upregulating DLG3 via sponging microRNA-211, inhibiting cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are implicated in oral squamous cell carcinoma (OSCC) development.
- lncRNAs are promising biomarkers and therapeutic targets for OSCC.
Purpose of the Study:
- Investigate the role of lncRNA LINC01315 in OSCC.
- Elucidate the underlying molecular mechanisms of LINC01315 in OSCC progression.
Main Methods:
- RT-qPCR and western blot analysis to quantify gene expression.
- Dual-luciferase reporter gene, RIP, and FISH assays to determine molecular interactions.
- In vitro and in vivo experiments to assess functional effects on OSCC cells and tumor growth.
Main Results:
- LINC01315 and DLG3 were downregulated, while miR-211 was upregulated in OSCC.
- LINC01315 upregulates DLG3 by competitively binding to miR-211.
- LINC01315 knockdown promoted OSCC cell proliferation, migration, and invasion, and inhibited apoptosis, effects reversed by miR-211 inhibition.
- DLG3 activation of the Hippo signaling pathway suppressed OSCC progression.
Conclusions:
- LINC01315 acts as a tumor suppressor in OSCC.
- The LINC01315/miR-211/DLG3 axis regulates OSCC progression via the Hippo signaling pathway.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation


